Financhill
Sell
36

CGCLF Quote, Financials, Valuation and Earnings

Last price:
$20.90
Seasonality move :
0%
Day range:
$20.90 - $20.90
52-week range:
$20.90 - $22.10
Dividend yield:
5.5%
P/E ratio:
13.73x
P/S ratio:
0.54x
P/B ratio:
0.66x
Volume:
--
Avg. volume:
--
1-year change:
-5.43%
Market cap:
$518M
Revenue:
$946.9M
EPS (TTM):
$1.52
Period Ending 2021-03-31 2022-03-31 2023-03-31 2024-03-31 2025-03-31
Revenue $1.8B $1.8B $1.3B $1.1B $946.9M
Revenue Growth (YoY) -12.13% 2.11% -31.73% -11.38% -14.78%
 
Cost of Revenues $1.4B $1.5B $935.6M $817.6M $688.5M
Gross Profit $364.1M $379.2M $318.2M $293.5M $258.4M
Gross Profit Margin 20.24% 20.65% 25.38% 26.42% 27.29%
 
R&D Expenses -- -- -- -- --
Selling, General & Admin -- -- -- -- --
Other Inc / (Exp) -- -- -- -- --
Operating Expenses $325.8M $314.5M $194.1M $192.9M $188.6M
Operating Income $38.3M $64.7M $124.1M $100.7M $69.8M
 
Net Interest Expenses $3.7M $2.4M $548K $741.5K $197K
EBT. Incl. Unusual Items $45.8M -$344.1M $330.4M $114.7M $62.7M
Earnings of Discontinued Ops. -- -- -- -- --
Income Tax Expense $27.8M $4.4M $9M $22.3M $20.3M
Net Income to Company $45.8M -$344.1M $330.4M $114.7M $62.7M
 
Minority Interest in Earnings -$6.4M -$6.4M -$6.7M -$5.9M -$5.1M
Net Income to Common Excl Extra Items $11.6M -$354.9M $314.7M $86.5M $37.3M
 
Basic EPS (Cont. Ops) $0.29 -$8.77 $9.05 $3.49 $1.50
Diluted EPS (Cont. Ops) $0.29 -$8.77 $9.05 $3.49 $1.50
Weighted Average Basic Share $40.5M $40.5M $34.8M $24.8M $24.8M
Weighted Average Diluted Share $40.5M $40.5M $34.8M $24.8M $24.8M
 
EBITDA $171.1M -$232.8M $399.7M $180.3M $123M
EBIT $49.9M -$341.4M $332.8M $117.2M $64.6M
 
Revenue (Reported) $1.8B $1.8B $1.3B $1.1B $946.9M
Operating Income (Reported) $38.3M $64.7M $124.1M $100.7M $69.8M
Operating Income (Adjusted) $49.9M -$341.4M $332.8M $117.2M $64.6M
Period Ending 2020-12-31 2021-12-31 2022-12-31 2023-12-31 2024-12-31
Revenue $507.1M $472M $332.2M $282.8M $245.3M
Revenue Growth (YoY) -2.86% -6.93% -29.62% -14.87% -13.7%
 
Cost of Revenues $400.3M $380.5M $249.2M $203M $172.7M
Gross Profit $106.8M $91.5M $83M $79.8M $72.6M
Gross Profit Margin 21.05% 19.38% 24.98% 28.22% 29.59%
 
R&D Expenses -- -- -- -- --
Selling, General & Admin -- -- -- -- --
Other Inc / (Exp) -- -- -- -- --
Operating Expenses $86M $79M $47M $49M $48.4M
Operating Income $20.7M $12.5M $36M $30.8M $24.2M
 
Net Interest Expenses $928.8K $571.8K $503.6K $331.9K $183.6K
EBT. Incl. Unusual Items $27M $17.1M $39.2M $31.2M $31.8M
Earnings of Discontinued Ops. -- -- -- -- --
Income Tax Expense $5.7M $4.2M $3.1M $5.6M $3.4M
Net Income to Company -- -- -- -- --
 
Minority Interest in Earnings -$1.8M -$1.6M -$1.6M -$1M -$1.6M
Net Income to Common Excl Extra Items $19.5M $11.3M $34.6M $24.6M $26.8M
 
Basic EPS (Cont. Ops) $0.48 $0.28 $1.06 $0.99 $1.08
Diluted EPS (Cont. Ops) $0.48 $0.28 $1.06 $0.99 $1.08
Weighted Average Basic Share $40.5M $40.5M $34.3M $24.8M $24.8M
Weighted Average Diluted Share $40.5M $40.5M $34.3M $24.8M $24.8M
 
EBITDA $28M $17.7M $39.9M $31.8M $32.3M
EBIT $28M $17.7M $39.9M $31.8M $32.3M
 
Revenue (Reported) $507.1M $472M $332.2M $282.8M $245.3M
Operating Income (Reported) $20.7M $12.5M $36M $30.8M $24.2M
Operating Income (Adjusted) $28M $17.7M $39.9M $31.8M $32.3M
Period Ending 2021-03-31 2022-03-31 2023-03-31 2024-03-31 2025-03-31
Revenue $1.8B $1.8B $1.3B $1.1B $957.7M
Revenue Growth (YoY) -- -- -- -- --
 
Cost of Revenues $1.4B $1.5B $933.6M $817.7M $696.3M
Gross Profit $364.5M $378.3M $317.8M $292.9M $261.4M
Gross Profit Margin -- -- -- -- --
 
R&D Expenses -- -- -- -- --
Selling, General & Admin -- -- -- -- --
Other Inc / (Exp) -- -- -- -- --
Operating Expenses $325.9M $314.2M $194M $192.7M $190.9M
Operating Income $38.6M $64.1M $123.7M $100.2M $70.5M
 
Net Interest Expenses $3.7M $2.4M $503K $763.6K $203.7K
EBT. Incl. Unusual Items $46.1M -$329.8M $332.3M $114.6M $63.4M
Earnings of Discontinued Ops. -- -- -- -- --
Income Tax Expense $27.9M $5.1M $8.8M $22.4M $20.5M
Net Income to Company -- -- -- -- --
 
Minority Interest in Earnings -$6.4M -$6.3M -$6.7M -$6M -$5.2M
Net Income to Common Excl Extra Items $11.8M -$341.3M $316.8M $86.3M $37.7M
 
Basic EPS (Cont. Ops) $0.29 -$8.43 $9.12 $3.48 $1.52
Diluted EPS (Cont. Ops) $0.29 -$8.43 $9.12 $3.48 $1.52
Weighted Average Basic Share
Weighted Average Diluted Share
 
EBITDA $50.2M -$327.1M $334.7M $117.1M $124.4M
EBIT $50.2M -$327.1M $334.7M $117.1M $65.4M
 
Revenue (Reported) $1.8B $1.8B $1.3B $1.1B $957.7M
Operating Income (Reported) $38.6M $64.1M $123.7M $100.2M $70.5M
Operating Income (Adjusted) $50.2M -$327.1M $334.7M $117.1M $65.4M
Period Ending 2021-12-31 2022-12-31 2023-12-31 2024-12-31 2025-12-31
Revenue $1.4B $916.6M $844.7M $468.8M --
Revenue Growth (YoY) -- -- -- -- --
 
Cost of Revenues $1.1B $682.4M $626.3M $331.5M --
Gross Profit $271.1M $234.2M $218.5M $137.3M --
Gross Profit Margin -- -- -- -- --
 
R&D Expenses -- -- -- -- --
Selling, General & Admin -- -- -- -- --
Other Inc / (Exp) -- -- -- -- --
Operating Expenses $234.9M $142.8M $145M $94.2M --
Operating Income $36.2M $91.5M $73.4M $43M --
 
Net Interest Expenses $2M $771.4K $1M $485.1K --
EBT. Incl. Unusual Items $59.3M $177.8M $89.2M $58.7M --
Earnings of Discontinued Ops. -- -- -- -- --
Income Tax Expense $17.3M $12.6M $19.3M $10.1M --
Net Income to Company -- -- -- -- --
 
Minority Interest in Earnings -$3.9M -$5.5M -$5M -$2.4M --
Net Income to Common Excl Extra Items $38.1M $159.6M $64.9M $46.1M --
 
Basic EPS (Cont. Ops) $0.94 $4.18 $2.62 $1.86 --
Diluted EPS (Cont. Ops) $0.94 $4.18 $2.62 $1.86 --
Weighted Average Basic Share $121.4M $114.3M $74.3M $49.6M --
Weighted Average Diluted Share $121.4M $114.3M $74.3M $49.6M --
 
EBITDA $61.5M $179.4M $91M $59.7M --
EBIT $61.5M $179.4M $91M $59.7M --
 
Revenue (Reported) $1.4B $916.6M $844.7M $468.8M --
Operating Income (Reported) $36.2M $91.5M $73.4M $43M --
Operating Income (Adjusted) $61.5M $179.4M $91M $59.7M --
Period Ending 2021-03-31 2022-03-31 2023-03-31 2024-03-31 2025-03-31
Cash and Equivalents $253.6M $231.2M $133.9M $138.7M $170.3M
Short Term Investments -- -- -- -- --
Accounts Receivable, Net $430.3M $401.5M $322.5M $281.8M $262.1M
Inventory $468.4M $473.1M $373.6M $324.2M $315.5M
Prepaid Expenses -- -- -- -- --
Other Current Assets $45.3M $48.7M $33.7M $20.3M $19.9M
Total Current Assets $1.2B $1.2B $863.8M $765.1M $767.8M
 
Property Plant And Equipment $937.2M $827.9M $524.6M $424.2M $406.7M
Long-Term Investments -- -- -- -- --
Goodwill -- -- -- -- --
Other Intangibles $12.5M $10.8M $7.4M $5.5M $7.1M
Other Long-Term Assets $17.9M $16.5M $7.4M $7.2M $8.1M
Total Assets $2.6B $2.4B $1.7B $1.4B $1.4B
 
Accounts Payable $167.6M $181.1M $162.7M $105.1M $100M
Accrued Expenses -- -- -- -- --
Current Portion Of Long-Term Debt -- -- -- -- --
Current Portion Of Capital Lease Obligations -- -- -- -- --
Other Current Liabilities $93.2M $143M $59.1M $50.3M $58.8M
Total Current Liabilities $535.9M $929M $458.4M $297.3M $328.1M
 
Long-Term Debt $397.8M $304.8M $332.7M $275.6M $177.8M
Capital Leases -- -- -- -- --
Total Liabilities $1B $1.3B $849.8M $623.4M $559.8M
 
Common Stock $164.7M $148.9M $136.4M $120M $121.4M
Other Common Equity Adj -- -- -- -- --
Common Equity $1.5B $1B $776.6M $759.2M $780.1M
Total Preferred Equity -- -- -- -- --
Minority Interest, Total $31.8M $32.6M $32.9M $33.9M $29M
Total Equity $1.5B $1.1B $809.5M $793.2M $809.1M
 
Total Liabilities and Equity $2.6B $2.4B $1.7B $1.4B $1.4B
Cash and Short Terms $253.6M $231.2M $133.9M $138.7M $170.3M
Total Debt $568.4M $367.4M $488.5M $350.2M $282.8M
Period Ending 2021-03-31 2022-03-31 2023-03-31 2024-03-31 2025-03-31
Cash and Equivalents $253.6M $231.2M $133.9M $138.7M $170.3M
Short Term Investments -- -- -- -- --
Accounts Receivable, Net $430.3M $401.5M $322.5M $281.8M $262.1M
Inventory $468.4M $473.1M $373.6M $324.2M $315.5M
Prepaid Expenses -- -- -- -- --
Other Current Assets $45.3M $48.7M $33.7M $20.3M $19.9M
Total Current Assets $1.2B $1.2B $863.8M $765.1M $767.8M
 
Property Plant And Equipment $937.2M $827.9M $524.6M $424.2M $406.7M
Long-Term Investments -- -- -- -- --
Goodwill -- -- -- -- --
Other Intangibles $12.5M $10.8M $7.4M $5.5M $7.1M
Other Long-Term Assets $17.9M $16.5M $7.4M $7.2M $8.1M
Total Assets $2.6B $2.4B $1.7B $1.4B $1.4B
 
Accounts Payable $167.6M $181.1M $162.7M $105.1M $100M
Accrued Expenses -- -- -- -- --
Current Portion Of Long-Term Debt -- -- -- -- --
Current Portion Of Capital Lease Obligations -- -- -- -- --
Other Current Liabilities $93.2M $143M $59.1M $50.3M $58.8M
Total Current Liabilities $535.9M $929M $458.4M $297.3M $328.1M
 
Long-Term Debt $397.8M $304.8M $332.7M $275.6M $177.8M
Capital Leases -- -- -- -- --
Total Liabilities $1B $1.3B $849.8M $623.4M $559.8M
 
Common Stock $164.7M $148.9M $136.4M $120M $121.4M
Other Common Equity Adj -- -- -- -- --
Common Equity -- -- -- -- --
Total Preferred Equity -- -- -- -- --
Minority Interest, Total $31.8M $32.6M $32.9M $33.9M $29M
Total Equity $1.5B $1.1B $809.5M $793.2M $809.1M
 
Total Liabilities and Equity $2.6B $2.4B $1.7B $1.4B $1.4B
Cash and Short Terms $253.6M $231.2M $133.9M $138.7M $170.3M
Total Debt $568.4M $367.4M $488.5M $350.2M $282.8M
Period Ending 2021-03-31 2022-03-31 2023-03-31 2024-03-31 2025-03-31
Net Income to Stockholders $45.8M -$344.1M $330.4M $114.7M $62.7M
Depreciation & Amoritzation $121.2M $108.5M $66.9M $63.2M $58.4M
Stock-Based Compensation -- -- -- -- --
Change in Accounts Receivable $43.9M $7.5M -$10.3M $10.4M $24.9M
Change in Inventories $8.2M -$37.3M -$40.3M $18.2M $16.1M
Cash From Operations $169M $132.5M $122.9M $154.1M $154.9M
 
Capital Expenditures $70.6M $74M $47.1M $49.2M $36.7M
Cash Acquisitions $2.2M $4M -$57.2M $2.2M --
Cash From Investing -$35.3M -$16.4M $147.8M -$23.1M -$27.9M
 
Dividends Paid (Ex Special Dividend) -$28.6M -$27M -$22.1M -$23.4M -$30.9M
Special Dividend Paid
Long-Term Debt Issued $141.5M -- $192.5M $34.6M --
Long-Term Debt Repaid -$64.6M -$158.8M -$49.5M -$130.7M -$50M
Repurchase of Common Stock -$18.9K -$8.9K -$402.7M -$13.9K -$19.7K
Other Financing Activities -$1.7M -$1.7M -$866.5K -$616.8K -$676.2K
Cash From Financing -$123.8M -$113.5M -$348.4M -$110.7M -$115.3M
 
Beginning Cash (CF) $235.9M $232.3M $199.3M $115.5M $130.4M
Foreign Exchange Rate Adjustment -- -- -- -- --
Additions / Reductions $10M $2.6M -$77.6M $20.3M $11.7M
Ending Cash (CF) $246M $239.7M $123.5M $137.6M $144.7M
 
Levered Free Cash Flow $98.5M $58.5M $75.8M $104.9M $118.1M
Period Ending 2007-03-31 2008-03-31 2009-03-31 2010-03-31 2011-03-31
Net Income to Stockholders -- -- -- -$1.3M $32.2M
Depreciation & Amoritzation -- -- -- $37.7M $34.9M
Stock-Based Compensation -- -- -- -- --
Change in Accounts Receivable -- -- -- -$621.7K $53.4M
Change in Inventories -- -- -- $23.9M -$1.4M
Cash From Operations -- -- -- $57M $75.3M
 
Capital Expenditures -- -- -- $28.2M $19.8M
Cash Acquisitions -- -- -- -- --
Cash From Investing -- -- -- -$31.4M -$18.6M
 
Dividends Paid (Ex Special Dividend) -- -- -- $524.4K $628K
Special Dividend Paid -- -- -- -- --
Long-Term Debt Issued -- -- -- -- --
Long-Term Debt Repaid -- -- -- -$216.8M -$32.3M
Repurchase of Common Stock -- -- -- -$164.7K -$12.6M
Other Financing Activities -- -- -- $350 -$9.6K
Cash From Financing -- -- -- -$24.4M -$8.4M
 
Beginning Cash (CF) -- -- -- $209.5M $288M
Foreign Exchange Rate Adjustment -- -- -- $203.6K -$340.8K
Additions / Reductions -- -- -- $1.1M $48.3M
Ending Cash (CF) -- -- -- $206.1M $326.4M
 
Levered Free Cash Flow -- -- -- $28.8M $55.4M
Period Ending 2007-12-31 2008-12-31 2009-12-31 2010-12-31 2011-12-31
Net Income to Stockholders -- -- -- $52.4M --
Depreciation & Amoritzation -- -- -- $156.6M --
Stock-Based Compensation -- -- -- -- --
Change in Accounts Receivable -- -- -- -$41M --
Change in Inventories -- -- -- $37.4M --
Cash From Operations -- -- -- $228M --
 
Capital Expenditures -- -- $60.8M $109M $19.8M
Cash Acquisitions -- -- -- -- --
Cash From Investing -- -- -- -$114.4M --
 
Dividends Paid (Ex Special Dividend) -- -- -$16.5M -$14.9M $628K
Special Dividend Paid
Long-Term Debt Issued -- -- -- -- --
Long-Term Debt Repaid -- -- -- -$242.9M --
Repurchase of Common Stock -- -- -- -$346.3K --
Other Financing Activities -- -- -- -$48.1K --
Cash From Financing -- -- -- -$59.1M --
 
Beginning Cash (CF) -- -- -- -- --
Foreign Exchange Rate Adjustment -- -- -- -- --
Additions / Reductions -- -- -- $54.6M --
Ending Cash (CF) -- -- -- -- --
 
Levered Free Cash Flow -- -- -- $119M --
Period Ending 2021-06-01 2022-06-01 2023-06-01 2024-06-01
Net Income to Stockholders -- -- -- -- --
Depreciation & Amoritzation -- -- -- -- --
Stock-Based Compensation -- -- -- -- --
Change in Accounts Receivable -- -- -- -- --
Change in Inventories -- -- -- -- --
Cash From Operations -- -- -- -- --
 
Capital Expenditures -- -- -- -- --
Cash Acquisitions -- -- -- -- --
Cash From Investing -- -- -- -- --
 
Dividends Paid (Ex Special Dividend) -- -- -- -- --
Special Dividend Paid -- -- -- -- --
Long-Term Debt Issued -- -- -- -- --
Long-Term Debt Repaid -- -- -- -- --
Repurchase of Common Stock -- -- -- -- --
Other Financing Activities -- -- -- -- --
Cash From Financing -- -- -- -- --
 
Beginning Cash (CF) -- -- -- -- --
Foreign Exchange Rate Adjustment -- -- -- -- --
Additions / Reductions -- -- -- -- --
Ending Cash (CF) -- -- -- -- --
 
Levered Free Cash Flow -- -- -- -- --

SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS

GET BETTER TRADE IDEAS

Popular

Where Will Salesforce Stock Be in 5 Years?
Where Will Salesforce Stock Be in 5 Years?

Salesforce (NYSE: CRM) just turned in a quarter that, on…

2 Ultra Safe Dividend Stocks to Buy Now
2 Ultra Safe Dividend Stocks to Buy Now

Historically, blue-chip dividend stocks have been good choices for periods…

Where Will Asana Stock Be in 5 Years?
Where Will Asana Stock Be in 5 Years?

Asana stock hasn’t given many investors on Wall Street any…

Stock Ideas

Buy
67
Is MSFT Stock a Buy?

Market Cap: $3.4T
P/E Ratio: 39x

Buy
65
Is NVDA Stock a Buy?

Market Cap: $3.3T
P/E Ratio: 46x

Sell
40
Is AAPL Stock a Buy?

Market Cap: $3T
P/E Ratio: 33x

Alerts

Sell
31
REGN alert for May 31

Regeneron Pharmaceuticals [REGN] is down 19.04% over the past day.

Buy
55
RGC alert for May 31

Regencell Bioscience Holdings [RGC] is up 16.13% over the past day.

Sell
42
AMBA alert for May 31

Ambarella [AMBA] is down 15.13% over the past day.

THE #1 STOCK ANALYSIS TOOL
TO MAKE SMARTER BUY AND SELL DECISIONS

Show me the best stock